FDA statement on relationship between bisphosphonate use and atypical subtrochanteric and femoral shaft fractures: a considered opinion
- PMID: 20729431
- DOI: 10.2214/AJR.10.4906
FDA statement on relationship between bisphosphonate use and atypical subtrochanteric and femoral shaft fractures: a considered opinion
Comment in
-
Atypical proximal femoral fractures in patients with paget disease receiving bisphosphonate therapy.AJR Am J Roentgenol. 2011 Jul;197(1):W196-7. doi: 10.2214/AJR.10.6343. AJR Am J Roentgenol. 2011. PMID: 21700989 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical